E
Epoch Biodesign
Biotech & Life Sciences · London, United Kingdom · Founded 2019
Designing and scaling the first enzymes capable of transforming plastics into low-carbon, circular chemicals MoreLess
Epoch Biodesign is a pioneering startup focused on developing natural solutions to tackle environmental challenges, particularly plastic pollution. The company operates at the intersection of computational and biological sciences, leveraging the latest advancements in these fields to create innovative enzymatic processes. These enzymes are designed to break down plastics, offering a sustainable alternative to traditional recycling methods.
Epoch Biodesign serves a diverse range of clients, including industrial manufacturers, waste management companies, and environmental organizations. These clients are looking for effective and scalable solutions to manage plastic waste and reduce their environmental footprint. By providing these enzymatic solutions, Epoch helps its clients meet regulatory requirements and achieve their sustainability goals.
The market Epoch operates in is the environmental biotechnology sector, which is rapidly growing due to increasing awareness and regulatory pressure to address climate change and pollution. This market is characterized by a high demand for innovative technologies that can provide practical and scalable solutions to environmental problems.
Epoch Biodesign's business model is based on the development and commercialization of its proprietary enzymatic processes. The company generates revenue through licensing agreements, partnerships, and direct sales of its enzyme-based solutions. By collaborating with industry leaders and securing funding from investors like Lowercarbon Capital, Epoch is well-positioned to scale its operations and expand its market reach.
In summary, Epoch Biodesign is a forward-thinking company that combines expertise in computational and biological sciences to create groundbreaking enzymatic solutions for plastic waste management. By addressing a critical environmental issue, the company not only helps its clients achieve sustainability but also contributes to a healthier planet.
Keywords: enzymatic processes, plastic recycling, environmental biotechnology, sustainability, computational biology, biological sciences, industrial solutions, waste management, pollution control, innovative technology.
Company overview
Epoch Biodesign company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- London, United Kingdom
- Employees
- 57
- Open positions
- 2
- Dealroom signal
- 91.2
Valuation & funding
Epoch Biodesign funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Mar 2026 | $12M | $92M | Lululemon · Extantia Capital · KOMPAS VC · Happiness Capital | ↗ |
| GRANT✓Other financing | Mar 2025 | $1M | — | Government of the United Kingdom | ↗ |
| SERIES A✓Equity / VC | Mar 2025 | $18M | $73M | Inditex · Happiness Capital · Kibo Invest · Lowercarbon Capital | ↗ |
| GRANT✓Other financing | Feb 2025 | $924K | — | UK Research and Innovation | — |
| SEED✓Equity / VC | Jun 2022 | $11M | $44M | Zero Carbon Capital · The Venture Collective · MCJ Collective · Amadeus Capital Partners | ↗ |
| SEEDEquity / VC | Jan 2022 | Plug and Play | — | ||
| GRANTOther financing | Mar 2021 | Undisclosed | — | ||
| GRANTOther financing | Oct 2020 | Undisclosed | — | ||
| GRANTOther financing | Mar 2020 | Undisclosed | — | ||
| SEEDEquity / VC | Jul 2019 | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 80 |
| 2025 | 50 |
| 2024 | 29 |
| 2023 | 27 |
| 2022 | 20 |
| 2021 | 14 |
Growth signals
Epoch Biodesign website traffic
Latest recorded traffic for Epoch Biodesign is 5.1K monthly website visits, up 6.3% over the last three months. Epoch Biodesign's team grew 14% over the past year.
Hiring
Open positions at Epoch Biodesign
Current openings linked to this company in Dealroom.
Comparisons
Epoch Biodesign compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Epoch Biodesign's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Epoch Biodesign has talent and traffic
team presence
In the news
Latest news about Epoch Biodesign
Recent press, funding announcements, and product moves mentioning Epoch Biodesign — open to read from the original sources.
Market sentiment
What the market is saying about Epoch Biodesign
An AI-synthesized read of the highest-engagement posts about Epoch Biodesign on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Epoch Biodesign’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





























